Sonelokimab — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09-28 in 3mo
ESTIMATED |
READOUT
An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcu
Phase 3 · Hidradenitis Suppurativa |
MLTX MoonLake Immunotherapeutics | Sonelokimab |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|